Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 59

    1.

    Can Serum be Used for Analyzing the EGFR Mutation Status in Patients with Advanced Non-small Cell Lung Cancer?

    Kim ST, Jung HY, Sung JS, Jo UH, Tanaka T, Hagiwara K, Park KH, Shin SW, Kim JS, Kim YH.

    Am J Clin Oncol. 2012 Jan 10. [Epub ahead of print]

    PMID:
    22237146
    [PubMed - as supplied by publisher]
    2.

    Lung cancer risk among construction workers in California, 1988-2007.

    Calvert GM, Luckhaupt S, Lee SJ, Cress R, Schumacher P, Shen R, Tak S, Deapen D.

    Am J Ind Med. 2012 May;55(5):412-22. doi: 10.1002/ajim.22010. Epub 2012 Jan 11.

    PMID:
    22237930
    [PubMed - in process]
    3.

    Selective diaphragm muscle weakness after contractile inactivity during thoracic surgery.

    Welvaart WN, Paul MA, Stienen GJ, van Hees HW, Loer SA, Bouwman R, Niessen H, de Man FS, Witt CC, Granzier H, Vonk-Noordegraaf A, Ottenheijm CA.

    Ann Surg. 2011 Dec;254(6):1044-9.

    PMID:
    21975323
    [PubMed - indexed for MEDLINE]
    4.

    Lymphatic vessel invasion is a significant prognostic indicator in stage IA lung adenocarcinoma.

    Funai K, Sugimura H, Morita T, Shundo Y, Shimizu K, Shiiya N.

    Ann Surg Oncol. 2011 Oct;18(10):2968-72. Epub 2011 Apr 22.

    PMID:
    21512862
    [PubMed - indexed for MEDLINE]
    5.

    Estimating the asbestos-related lung cancer burden from mesothelioma mortality.

    McCormack V, Peto J, Byrnes G, Straif K, Boffetta P.

    Br J Cancer. 2012 Jan 31;106(3):575-84. doi: 10.1038/bjc.2011.563. Epub 2012 Jan 10.

    PMID:
    22233924
    [PubMed - indexed for MEDLINE]
    6.

    Celecoxib may prevent lung cancer.

    Printz C.

    Cancer. 2012 Jan 1;118(1):3. doi: 10.1002/cncr.27371. No abstract available.

    PMID:
    22222881
    [PubMed - indexed for MEDLINE]
    7.

    Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis.

    Labelle M, Begum S, Hynes RO.

    Cancer Cell. 2011 Nov 15;20(5):576-90.

    PMID:
    22094253
    [PubMed - indexed for MEDLINE]
    8.

    Phase I and pharmacologic study of weekly amrubicin in patients with refractory or relapsed lung cancer: Central Japan Lung Study Group (CJLSG) 0601 trial.

    Kitagawa C, Saka H, Kajikawa S, Mori K, Oki M, Suzuki R.

    Cancer Chemother Pharmacol. 2012 May;69(5):1379-85. Epub 2012 Jan 12.

    PMID:
    22237957
    [PubMed - in process]
    9.

    Preclinical evaluation of the novel multi-targeted agent R1530.

    Kolinsky K, Tovar C, Zhang YE, Railkar A, Yang H, Carvajal D, Nevins T, Geng W, Linn M, Packman K, Liu JJ, Zhang Z, Wovkulich P, Ju G, Higgins B.

    Cancer Chemother Pharmacol. 2011 Dec;68(6):1585-94. Epub 2011 May 8.

    PMID:
    21553286
    [PubMed - indexed for MEDLINE]
    10.

    Comparison of different semi-mechanistic models for chemotherapy-related neutropenia: application to BI 2536 a Plk-1 inhibitor.

    Soto E, Staab A, Doege C, Freiwald M, Munzert G, Trocóniz IF.

    Cancer Chemother Pharmacol. 2011 Dec;68(6):1517-27. Epub 2011 Apr 24.

    PMID:
    21516508
    [PubMed - indexed for MEDLINE]
    11.

    Smac: Its role in apoptosis induction and use in lung cancer diagnosis and treatment.

    Qin S, Yang C, Li S, Xu C, Zhao Y, Ren H.

    Cancer Lett. 2012 May 1;318(1):9-13. Epub 2012 Jan 3. Review.

    PMID:
    22227574
    [PubMed - indexed for MEDLINE]
    12.

    PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis.

    Zigler M, Kamiya T, Brantley EC, Villares GJ, Bar-Eli M.

    Cancer Res. 2011 Nov 1;71(21):6561-6. Epub 2011 Oct 18. Review.

    PMID:
    22009534
    [PubMed - indexed for MEDLINE]
    13.

    Antiangiogenic and antimetastatic activity of JAK inhibitor AZD1480.

    Xin H, Herrmann A, Reckamp K, Zhang W, Pal S, Hedvat M, Zhang C, Liang W, Scuto A, Weng S, Morosini D, Cao ZA, Zinda M, Figlin R, Huszar D, Jove R, Yu H.

    Cancer Res. 2011 Nov 1;71(21):6601-10. Epub 2011 Sep 15.

    PMID:
    21920898
    [PubMed - indexed for MEDLINE]
    14.

    Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity.

    Yi H, Guo C, Yu X, Gao P, Qian J, Zuo D, Manjili MH, Fisher PB, Subjeck JR, Wang XY.

    Cancer Res. 2011 Nov 1;71(21):6611-20. Epub 2011 Sep 13.

    PMID:
    21914786
    [PubMed - indexed for MEDLINE]
    15.

    Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer.

    Doebele RC, Pilling AB, Aisner DL, Kutateladze TG, Le AT, Weickhardt AJ, Kondo KL, Linderman DJ, Heasley LE, Franklin WA, Varella-Garcia M, Camidge DR.

    Clin Cancer Res. 2012 Mar 1;18(5):1472-82. Epub 2012 Jan 10.

    PMID:
    22235099
    [PubMed - in process]
    Free PMC Article
    16.

    Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker.

    Pietanza MC, Kadota K, Huberman K, Sima CS, Fiore JJ, Sumner DK, Travis WD, Heguy A, Ginsberg MS, Holodny AI, Chan TA, Rizvi NA, Azzoli CG, Riely GJ, Kris MG, Krug LM.

    Clin Cancer Res. 2012 Feb 15;18(4):1138-45. Epub 2012 Jan 6.

    PMID:
    22228633
    [PubMed - in process]
    17.

    Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis.

    Valencia K, Ormazábal C, Zandueta C, Luis-Ravelo D, Antón I, Pajares MJ, Agorreta J, Montuenga LM, Martínez-Canarias S, Leitinger B, Lecanda F.

    Clin Cancer Res. 2012 Feb 15;18(4):969-80. Epub 2012 Jan 5.

    PMID:
    22223527
    [PubMed - in process]
    18.

    A low-toxicity IL-2-based immunocytokine retains antitumor activity despite its high degree of IL-2 receptor selectivity.

    Gillies SD, Lan Y, Hettmann T, Brunkhorst B, Sun Y, Mueller SO, Lo KM.

    Clin Cancer Res. 2011 Jun 1;17(11):3673-85. Epub 2011 Apr 29.

    PMID:
    21531812
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    Genomic profiles specific to patient ethnicity in lung adenocarcinoma.

    Broët P, Dalmasso C, Tan EH, Alifano M, Zhang S, Wu J, Lee MH, Régnard JF, Lim D, Koong HN, Agasthian T, Miller LD, Lim E, Camilleri-Broët S, Tan P.

    Clin Cancer Res. 2011 Jun 1;17(11):3542-50. Epub 2011 Apr 26.

    PMID:
    21521776
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Inhibition of Polo-like kinase 1 prevents the growth of metastatic breast cancer cells in the brain.

    Qian Y, Hua E, Bisht K, Woditschka S, Skordos KW, Liewehr DJ, Steinberg SM, Brogi E, Akram MM, Killian JK, Edelman DC, Pineda M, Scurci S, Degenhardt YY, Laquerre S, Lampkin TA, Meltzer PS, Camphausen K, Steeg PS, Palmieri D.

    Clin Exp Metastasis. 2011 Dec;28(8):899-908. Epub 2011 Sep 21.

    PMID:
    21953073
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk